Corporate Luncheon Workshops
The Corporate Luncheon Workshops are independent from the ISLH educational content. Please review the available workshops below and pre-register for any workshops that you wish to attend. There is no cost to attend these workshops. Corporate luncheon workshops are limited to meeting attendees. Details are subject to change.
How to Register
If you have already registered for the conference
You may access the workshop registration system by
logging into your account and clicking on the "Register Now" link in the Luncheon Workshop column of your conference registration record.
If you have not yet registered for the conference
Click here to first submit your conference registration. You will then be able to register for a luncheon workshop.
Corporate Luncheon Workshops
Thursday, May 4
(12:00 PM - 1:30 PM)
Economic and Clinical Efficiency in the Hematology Lab
Chair: Anna Maria Cenci, SIPMeL – Società Italiana di Patologia Clinica e Medicina di Laboratorio, Italy
Speakers:
1. Mike Samoszuk, MD, VP and Chief Medical Officer, Beckman Coulter: “Automated Platelet Counting Technologies in Hematological Analyzers”
2. Dwight Denham, VP Global Health Economics and Reimbursement, Danaher Corporation, “Value of D: Increasing Burden of Proof for Value in a Constrained Global Healthcare System”
Hematology Reinvented: Technology overview and first experiences with the cobas m 511 integrated hematology analyzer=
Speakers:
1. Dr. David Zahniser
2. Dr. Henk Russcher
Description: Roche has recently launched the cobas m 511 integrated hematology analyzer for countries that accept the CE mark. In this session, Dr. David Zahniser will share the innovative Bloodhound technology that uses multi-spectral digital imaging to reinvent the way hematology testing is done. In addition, Dr. Henk Russcher, from Erasmus Medical Center, will share first experiences of working with the analyzer in their laboratory in connection with the Multi-Center Clinical trials.
Platelets Revisited
Title: Contribution of Automated Parameters in the Diagnosis of Platelet Disorders
Speaker: Professor Marie-Christine Alessi: Biological Hematology Service, CHU Timone, Marseille, France
Description: How laboratory investigations can help resolve the practical challenges presented when distinguishing inherited from acquired (immune) thrombocytopenia and between different causes of inherited thrombocytopenia.
Title: Reticulated Platelets (RPs) for Differential Diagnosis of Thrombocytopenia and Beyond
Speaker: Doctor Florian Prüller: Medical University of Graz, Austria
Description: Exploring the derivation, function and clinical significance of reticulated platelets and a new method of counting both them, and other by-products
Friday, May 5 (12:00 PM - 1:30 PM)
New solutions to address the productivity challenges of today’s high-volume laboratories
Title: Technology Overview and Early Experiences with a Novel, Prototype Hematology Analyzer in a Clinical Laboratory
Speakers:
1. Gabriella Lakos, MD, PhD, D (ABLMI), Senior Associate Medical Director, Abbott Hematology
2. Amin A. Mohammad, PhD, Director, Pathology Informatic Center, Scott & White Healthcare
Description:
Dr. Lakos will provide an overview of a prototype, high-throughput Hematology Analyzer and discuss how its capabilities will address the efficiency challenges within a high-volume lab setting. Dr. Mohammad will share his experiences with the system at Scott & White Memorial Healthcare, including early findings on comparing the performance of the prototype system’s novel optical platelet measurement method with that of the CELL-DYN Sapphire system’s CD61 immuno-platelet assay.
Title: CP3000 Coagulation System: Technical Characteristics and Results of a Multi-Center Study Including Five Other Coagulation Analyzers
Speaker: Larry Smith, PhD, Manager, Medical and Scientific Affairs, Hematology Business Unit, Abbott Diagnostics Division
Description: The CP3000 Coagulation System (Sekisui Medical, Japan) is a fully automated, compact coagulation analyzer, with high throughput (up to 400 PT/hour) and advanced workflow features. During this symposium, Dr. Smith will review the features of the CP3000 analyzer, including throughput and STAT capabilities and the novel automated mixing study functionality. He will also present data from a multi-center study comparing PT and INR results obtained with CP3000 to those generated with five other coagulation systems.
Current Issues and Challenges in Laboratory Diagnosis of Hemophilia and Monitoring Its Treatment
Chair: Dorothy M. Adcock M.D., Medical Director, Colorado Coagulation, Laboratory Corporation of America® Holdings, Englewood, Colorado
Speakers:
1. Stefan Tiefenbacher, PhD, Technical Director, Vice President Colorado Coagulation, Laboratory Corporation of America® Holdings, Englewood, Colorado
2. Connie H. Miller, PhD, Karna LLC, Independent Consultant to, Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Protection, Atlanta, Georgia
Description: This CME Luncheon symposium will focus on issues impacting laboratory diagnosis of hemophilia and accurate therapeutic factor monitoring. Using both didactic and case-based presentations, expert faculty will discuss common challenges and practical solutions. Topics to be covered include choice of diagnostic assay for non-severe hemophilia A; assay discrepancy in non-severe hemophilia A and B; and modified recombinant factor products and how to optimize accurate monitoring of activity levels. Overall, these presentations will increase awareness of new modified factors and their detection, minimize issues with factor measurement to ensure inaccurate dosing, and serve to improve the care of patients with hemophilia.
Innovations that Bring Value to Patient Management and Outcomes
Speakers:
1. Dr. Olga Pozdnyakova, MD, PhD, Associate Pathologist, Hematopathology Division, Associate Medical Director, Hematology Laboratory, Brigham & Women's Hospital, Boston, MA
2. Dr. Michele P. Lambert, MD, Medical Director, Special Coagulation Laboratory, Attending Physician, Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA
Description: As healthcare transforms from a volume to value based paradigm, the laboratory’s role is becoming increasingly dynamic. This session will explore the use of innovative technologies in both hematology and fluorescent flow cytometry that may lead to improved patient management. Discover how to enhance a traditional complete blood count (CBC) with Advanced Clinical Parameter hematology and multiparameter flow cytometry testing, which may directly aid in patient diagnosis and management. A series of clinical case studies will emphasize the impact that enhanced laboratory tests beyond the routine CBC can have on patient outcomes.
